ENGlobal Corp. (ENG)

1.04
0.00 (0.00)
NASDAQ : Industrial Services
Prev Close 1.04
Open 1.04
Day Low/High 1.01 / 1.04
52 Wk Low/High 0.48 / 1.33
Volume 4.29K
Avg Volume 29.60K
Exchange NASDAQ
Shares Outstanding 27.40M
Market Cap 28.50M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
ENGlobal Corp Stock Upgraded (ENG)

ENGlobal Corp Stock Upgraded (ENG)

ENGlobal (Nasdaq:ENG) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: ADEP, ALLB, ATAX, ENG, FULL, MBT, RSTI Downgrades: ACUR, BEAT, BIG, BWINB, CCJ, CHS, FAC, NAVI, PAR Initiations: VPCO Read on to get TheStreet Quant Ratings' detailed report:

ENGlobal Announces Technology Patents And Project Awards

ENGlobal Announces Technology Patents And Project Awards

Adds Subsea Business Manager to Support Subsea/Offshore Opportunities

4 Stocks Under $10 to Trade for Breakouts

4 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering major breakout trades.

5 Stocks Under $10 in Breakout Territory

5 Stocks Under $10 in Breakout Territory

These under-$10 stocks are within range of triggering breakout trades.

ENGlobal Announces Expansion Of Its Department Of Defense Contract

ENGlobal Announces Expansion Of Its Department Of Defense Contract

Solidifies 10 Year Client Relationship

ENGlobal Announces First Universal Master Control Station(TM) Installation

ENGlobal Announces First Universal Master Control Station(TM) Installation

Patent-Pending, Vendor-Independent Subsea Control System

ENGlobal Finalizes Sale Of Gulf Coast Operations

ENGlobal Finalizes Sale Of Gulf Coast Operations

Enters Into New $10 Million Credit Facility

ENGlobal Recognized With Safety Awards

ENGlobal Recognized With Safety Awards

ENGlobal Provides Operational Update

ENGlobal Provides Operational Update

ENGlobal Provides Corporate Update

ENGlobal Provides Corporate Update

Cramer's Top Stock Picks: IMGN ENG SGEN

Cramer's Top Stock Picks: IMGN ENG SGEN

Cramer said he's a fan of pipeline company Enbridge and likes what Immunogen and Seattle Genetics are doing to fight diseases.

TheStreet Quant Rating: D (Sell)